No influence of moderate hepatic impairment on the pharmacokinetics of lumiracoxib, an oral COX-2 selective inhibitor
2004 ◽
Vol 50
(2)
◽
pp. 181-186
◽
2006 ◽
Vol 46
(1)
◽
pp. 88-102
◽
Keyword(s):
2005 ◽
Vol 61
(4)
◽
pp. 247-256
◽
1995 ◽
Vol 29
(Supplement 2)
◽
pp. 49-61
◽
2008 ◽
Vol 13
(4)
◽
pp. 252-260
◽
Keyword(s):
2005 ◽
Vol 59
(5)
◽
pp. 598-601
◽